Literature DB >> 28631020

Utility of PAS and β-catenin staining in histological categorisation and prediction of prognosis of hepatoblastomas.

Goutam Bera1, Ram Narayan Das1, Paromita Roy2, Ranajoy Ghosh1, Nelofar Islam1, Prafulla Kumar Mishra3, Uttara Chatterjee4.   

Abstract

AIMS: The aim of this study was to assess the usefulness of PAS, β-catenin and Ki-67 in categorising hepatoblastomas (HBs) and their significance in predicting prognosis. In addition, we have also documented the various chemotherapy induced histologic changes in HBs.
METHOD: In this retrospective observational study of 29 cases of hepatoblastomas, 27 cases were considered for statistical analysis, excluding two cases of diagnostic core biopsies. All clinicopathological parameters and follow up data were collected. All HB cases including the mixed epithelial and mesenchymal HBs were classified into two groups: fetal predominant and embryonal predominant type according to the predominant epithelial component. PAS, β-catenin and Ki-67 staining were done and their correlation with histologic subtypes was assessed. Kaplan-Meier survival analysis was performed in relation to histology, PAS, β-catenin and Ki-67 staining characteristics. RESULT: Diffuse nuclear staining of β-catenin was significantly more common in embryonal predominant type (p = 0.036), whereas strong PAS positivity was significantly associated with fetal predominant type (p = 0.002). But no significant correlation was seen between histologic type and Ki-67 staining (p = 0.42). Survival analysis showed cases with diffuse PAS positivity, focal nuclear β-catenin staining and low Ki-67 LI had better survival.
CONCLUSION: PAS is a simple stain and can be utilised in histological categorisation of HB and also predicting its outcome. Nuclear β-catenin staining which is significantly common in embryonal elements in HB predicts shorter survival.

Entities:  

Keywords:  Hepatoblastoma; PAS stain; β-Catenin

Mesh:

Substances:

Year:  2017        PMID: 28631020     DOI: 10.1007/s00383-017-4115-2

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  22 in total

1.  Prognostic factors and staging systems in childhood hepatoblastoma.

Authors:  D von Schweinitz; H Hecker; G Schmidt-von-Arndt; D Harms
Journal:  Int J Cancer       Date:  1997-12-19       Impact factor: 7.396

2.  Relationship of β-catenin and postchemotherapy histopathologic changes with overall survival in patients with hepatoblastoma.

Authors:  Kirti Gupta; Swapnil Rane; Ashim Das; Ram Kumar Marwaha; Prema Menon; K L N Rao
Journal:  J Pediatr Hematol Oncol       Date:  2012-11       Impact factor: 1.289

3.  Association between hepatoblastoma and very low birth weight: a trend or a chance?

Authors:  H Ikeda; S Matsuyama; M Tanimura
Journal:  J Pediatr       Date:  1997-04       Impact factor: 4.406

4.  Histologic classification of liver-cell carcinoma in infancy and childhood and its clinical evaluation. A study of 70 cases collected in Japan.

Authors:  M Kasai; I Watanabe
Journal:  Cancer       Date:  1970-03       Impact factor: 6.860

5.  Immunohistochemical assessment of the MIB-1 Labeling Index in human hepatoblastoma and its prognostic relevance.

Authors:  T Ara; M Fukuzawa; T Oue; Y Komoto; T Kusafuka; K Imura; A Okada
Journal:  J Pediatr Surg       Date:  1997-12       Impact factor: 2.545

6.  FNAC Aided Diagnosis and Categorization of Hepatoblastoma:: A Report of Three Cases.

Authors:  Goutam Bera; Ram Narayan Das; Nelofar Islam; Paromita Roy; Prafulla Kumar Mishra; Chhanda Datta; Manoj Kumar Chaudhuri; Uttara Chatterjee
Journal:  Diagn Cytopathol       Date:  2016-09-15       Impact factor: 1.582

Review 7.  Primary liver tumours in children.

Authors:  A Vos
Journal:  Eur J Surg Oncol       Date:  1995-02       Impact factor: 4.424

8.  Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group study.

Authors:  E C Douglass; M Reynolds; M Finegold; A B Cantor; A Glicksman
Journal:  J Clin Oncol       Date:  1993-01       Impact factor: 44.544

Review 9.  Beckwith-Wiedemann syndrome.

Authors:  Rosanna Weksberg; Cheryl Shuman; J Bruce Beckwith
Journal:  Eur J Hum Genet       Date:  2010-01       Impact factor: 4.246

10.  HGF/c-Met related activation of β-catenin in hepatoblastoma.

Authors:  Rachel Purcell; Margaret Childs; Rudolf Maibach; Carina Miles; Clinton Turner; Arthur Zimmermann; Michael Sullivan
Journal:  J Exp Clin Cancer Res       Date:  2011-10-12
View more
  3 in total

1.  β-Catenin mutations as determinants of hepatoblastoma phenotypes in mice.

Authors:  Weiqi Zhang; Jennifer Meyfeldt; Huabo Wang; Sucheta Kulkarni; Jie Lu; Jordan A Mandel; Brady Marburger; Ying Liu; Joanna E Gorka; Sarangarajan Ranganathan; Edward V Prochownik
Journal:  J Biol Chem       Date:  2019-10-09       Impact factor: 5.157

2.  Common and Rare Histological Variants of Hepatoblastoma in Children: A Pathological Diagnosis and Review of the Literature.

Authors:  Sushma Bharti; Jyotsna Naresh Bharti; Arvind Sinha; Taruna Yadav
Journal:  Gastrointest Tumors       Date:  2021-02-04

Review 3.  Wnt/β-catenin signaling as a useful therapeutic target in hepatoblastoma.

Authors:  Ying-Li Sha; Shuang Liu; Wen-Wen Yan; Bo Dong
Journal:  Biosci Rep       Date:  2019-09-24       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.